1. Home
  2. ENVB vs NBY Comparison

ENVB vs NBY Comparison

Compare ENVB & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • NBY
  • Stock Information
  • Founded
  • ENVB 1994
  • NBY 2000
  • Country
  • ENVB United States
  • NBY United States
  • Employees
  • ENVB N/A
  • NBY N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • ENVB Health Care
  • NBY
  • Exchange
  • ENVB Nasdaq
  • NBY Nasdaq
  • Market Cap
  • ENVB 3.1M
  • NBY 3.4M
  • IPO Year
  • ENVB N/A
  • NBY 2007
  • Fundamental
  • Price
  • ENVB $1.29
  • NBY $0.60
  • Analyst Decision
  • ENVB Strong Buy
  • NBY Strong Buy
  • Analyst Count
  • ENVB 1
  • NBY 1
  • Target Price
  • ENVB $10.00
  • NBY $0.85
  • AVG Volume (30 Days)
  • ENVB 225.8K
  • NBY 32.5K
  • Earning Date
  • ENVB 08-11-2025
  • NBY 08-12-2025
  • Dividend Yield
  • ENVB N/A
  • NBY N/A
  • EPS Growth
  • ENVB N/A
  • NBY N/A
  • EPS
  • ENVB N/A
  • NBY 0.57
  • Revenue
  • ENVB N/A
  • NBY $9,781,000.00
  • Revenue This Year
  • ENVB N/A
  • NBY $23.91
  • Revenue Next Year
  • ENVB N/A
  • NBY $32.05
  • P/E Ratio
  • ENVB N/A
  • NBY $1.25
  • Revenue Growth
  • ENVB N/A
  • NBY 20.52
  • 52 Week Low
  • ENVB $1.01
  • NBY $0.36
  • 52 Week High
  • ENVB $11.55
  • NBY $2.47
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 45.37
  • NBY 52.90
  • Support Level
  • ENVB $1.18
  • NBY $0.56
  • Resistance Level
  • ENVB $1.31
  • NBY $0.64
  • Average True Range (ATR)
  • ENVB 0.07
  • NBY 0.03
  • MACD
  • ENVB 0.02
  • NBY 0.00
  • Stochastic Oscillator
  • ENVB 46.56
  • NBY 50.20

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: